Eledon Pharmaceuticals, Inc. - stock earnings
ELDN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -10.3 million USD | ? USD |
| 2023Q2 | -9.6 million USD | ? USD |
| 2023Q1 | -10.4 million USD | ? USD |
| 2022Q4 | -58.0 million USD | ? USD |
| 2022Q3 | -10.3 million USD | ? USD |
| 2022Q2 | -9.2 million USD | ? USD |
| 2022Q1 | -9.9 million USD | ? USD |
| 2021Q4 | -8.8 million USD | 120 USD |
| 2021Q3 | -9.8 million USD | ? USD |
| 2021Q2 | -7.4 million USD | ? USD |
| 2021Q1 | -8.5 million USD | 120000 USD |
| 2020Q4 | -5.9 million USD | 120000 USD |
| 2020Q3 | -6.1 million USD | 120000 USD |
| 2020Q2 | -2.6 million USD | ? USD |
| 2020Q1 | -8.2 million USD | ? USD |
| 2019Q4 | -4.1 million USD | ? USD |
| 2019Q3 | -2.9 million USD | ? USD |
| 2019Q2 | -4.1 million USD | ? USD |
| 2019Q1 | -4.9 million USD | ? USD |
| 2018Q4 | -4.6 million USD | ? USD |
| 2018Q3 | -3.5 million USD | ? USD |
| 2018Q2 | -3.2 million USD | ? USD |
| 2018Q1 | -2.1 million USD | ? USD |
| 2017Q4 | -2.1 million USD | ? USD |
| 2017Q3 | -3.0 million USD | ? USD |
| 2017Q2 | -6.7 million USD | ? USD |
| 2017Q1 | -3.9 million USD | ? USD |
| 2016Q4 | -3.7 million USD | ? USD |
| 2016Q3 | -9.3 million USD | ? USD |
| 2016Q2 | -13.5 million USD | ? USD |
| 2016Q1 | -11.4 million USD | ? USD |
| 2015Q4 | -11.0 million USD | ? USD |
| 2015Q3 | -11.9 million USD | ? USD |
| 2015Q2 | -9.0 million USD | ? USD |
| 2015Q1 | -13.3 million USD | ? USD |
| 2014Q4 | -6.2 million USD | ? USD |
| 2014Q3 | -6.4 million USD | ? USD |
| 2014Q2 | -5.9 million USD | ? USD |
| 2014Q1 | -4.8 million USD | ? USD |
| 2013Q4 | -5.5 million USD | ? USD |
| 2013Q3 | -3.4 million USD | ? USD |
ELDN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -89.1 million USD | ? USD |
| 2022 | -87.5 million USD | ? USD |
| 2021 | -34.5 million USD | 120000 USD |
| 2020 | -22.8 million USD | 120000 USD |
| 2019 | -17.9 million USD | ? USD |
| 2018 | -14.1 million USD | ? USD |
| 2017 | -13.1 million USD | ? USD |
| 2016 | -38.0 million USD | ? USD |
| 2015 | -45.1 million USD | ? USD |
| 2014 | -23.3 million USD | ? USD |
| 2013 | -15.7 million USD | ? USD |
| 2012 | -9.6 million USD | ? USD |
ELDN
Price: $2.41
52 week price:
Earnings Per Share: -1.64 USD
P/E Ratio: -0.33
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 24400
Market Capitalization: 41.9 million